CXCL2 and osteosarcoma: Specifically, miR-532-5p has been previously documented as a prognostic marker of osteosarcoma owing to its ability to inhibit the malignant phenotype of osteosarcoma by targeting chemokine ligand-2 (CXCL2) (20).